EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The residue 86 of the Getah virus E2 glycoprotein mediates both glycosaminoglycan- and LDLR-dependent infection

Xiangshu Qiu, Rongguang Lu, Jiaxin Tian, He Zhang, Jiyong Zhou, Mengsi Sun, Xinyu Cao, Xiangyu Zhu, Bocheng Liu, Qihui Yu, Yuanyuan Li, Hualei Wang und 3 weitere

PLOS Pathogens · 2026

DOI: 10.1371/journal.ppat.1014453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Xiangshu Qiu und 14 weiteren Autor:innen. Beteiligte Einrichtung: MOA Key Laboratory of Animal Virology, Zhejiang University Center for Veterinary Sciences, Hangzhou, China. Hauptthemen laut MEDLINE: Glycosaminoglycans, Receptors, LDL, Viral Envelope Proteins, Alphavirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Science and Technology Development Program of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Getah virus (GETV), a mosquito-borne alphavirus, poses an emerging threat to public health with its increasingly broad host spectrum. While glycosaminoglycans (GAGs) serve as critical attachment factors for many alphaviruses and the low-density lipoprotein receptor (LDLR) facilitates the cellular entry of several members, the precise viral determinants governing these interactions and their implications for viral virulence remain poorly defined. Here, we introduced an H86Y substitution, a potential adaptive mutation site, within the E2 glycoprotein of GETV using reverse genetics. The H86Y mutant replicated more efficiently in mosquito C6/36 cells but was consistently attenuated across several mammalian cell lines. In susceptible mouse models, H86Y infection led to reduced viral loads, milder histopathology, and lower inflammatory responses compared with the parental virus, yet still elicited robust protective immunity in adult mice. Mechanistically, a series of functional assays, including infection in GAG-deficient cells, decoy inhibition, co-immunoprecipitation, receptor overexpression and knockdown, and biolayer interferometry, demonstrated that the residue 86 in E2 glycoprotein is a critical determinant for GETV binding to both GAGs and LDLR. The H86Y mutation concurrently reduces these interactions, contributing the impairment of virus attachment and entry into mammalian cells. Furthermore, the GAG-binding site functionally overlaps with the LDLR interaction interface. In LDLR-deficient suckling mice, the impaired replication of H86Y persisted in examined tissues. However, pre-treatment with heparinase nearly completely eliminated this attenuation phenotype, further confirming that LDLR and GAG are the key host factors mediating attenuation phenotype for H86Y. In summary, the residue 86 of the GETV E2 glycoprotein represents a determinant of viral virulence, and an H86Y mutation attenuates GAGs and LDLR-dependent infection, providing mechanistic insights into alphavirus-host interactions and a potential target for antiviral and vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycosaminoglycansReceptors, LDLViral Envelope ProteinsAlphavirus InfectionsAlphavirusAnimalsMiceHumansFemale

Substanzen

GlycosaminoglycansReceptors, LDLViral Envelope Proteins

Autor:innen und Institutionen

  • MOA Key Laboratory of Animal Virology, Zhejiang University Center for Veterinary Sciences, Hangzhou, China.
  • State Key Laboratory of Pathogen and Biosecurity, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
  • Institute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen, China.
  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…

ORCID-Profile: Huijun Lu

Förderung

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • Science and Technology Development Program of Jilin Province
  • Jilin Provincial Scientific and Technological Development Program

Zitieren

APA

Qiu, X., Lu, R., Tian, J., Zhang, H., Zhou, J., Sun, M., Cao, X., Zhu, X., Liu, B., Yu, Q., Li, Y., Wang, H., Jin, N., Lu, H., & Shi, N. (2026). The residue 86 of the Getah virus E2 glycoprotein mediates both glycosaminoglycan- and LDLR-dependent infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014453

Vancouver

Qiu X, Lu R, Tian J, Zhang H, Zhou J, Sun M, et al. The residue 86 of the Getah virus E2 glycoprotein mediates both glycosaminoglycan- and LDLR-dependent infection. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014453

BibTeX
@article{Qiu2026,
  author = {Qiu, Xiangshu and Lu, Rongguang and Tian, Jiaxin and Zhang, He and Zhou, Jiyong and Sun, Mengsi and Cao, Xinyu and Zhu, Xiangyu and Liu, Bocheng and Yu, Qihui and Li, Yuanyuan and Wang, Hualei and Jin, Ningyi and Lu, Huijun and Shi, Ning},
  title = {The residue 86 of the Getah virus E2 glycoprotein mediates both glycosaminoglycan- and LDLR-dependent infection},
  journal = {PLOS Pathogens},
  year = {2026},
  doi = {10.1371/journal.ppat.1014453}
}
Kostenlos starten →